EP1804584A4 - Verfahren und zusammensetzungen im zusammenhang mit der verabreichung eines ganoderma-lucidum-extrakts - Google Patents

Verfahren und zusammensetzungen im zusammenhang mit der verabreichung eines ganoderma-lucidum-extrakts

Info

Publication number
EP1804584A4
EP1804584A4 EP05810080A EP05810080A EP1804584A4 EP 1804584 A4 EP1804584 A4 EP 1804584A4 EP 05810080 A EP05810080 A EP 05810080A EP 05810080 A EP05810080 A EP 05810080A EP 1804584 A4 EP1804584 A4 EP 1804584A4
Authority
EP
European Patent Office
Prior art keywords
administration
methods
ganoderma lucidum
lucidum extract
compositions associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP05810080A
Other languages
English (en)
French (fr)
Other versions
EP1804584A2 (de
Inventor
Chi-Huey Wong
Hsien-Yeh Hsu
Kuo-Feng Hua
Chun-Hung Lin
Jason Hsu
Shui-Tein Chen
Kuo-I Lin
Wen-Bin Yang
John Yu
Alice Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academia Sinica
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Publication of EP1804584A2 publication Critical patent/EP1804584A2/de
Publication of EP1804584A4 publication Critical patent/EP1804584A4/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
EP05810080A 2004-10-14 2005-10-14 Verfahren und zusammensetzungen im zusammenhang mit der verabreichung eines ganoderma-lucidum-extrakts Ceased EP1804584A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61926304P 2004-10-14 2004-10-14
PCT/US2005/036961 WO2006044616A2 (en) 2004-10-14 2005-10-14 Methods and compositions associated with administration of an extract of ganoderma lucidum

Publications (2)

Publication Number Publication Date
EP1804584A2 EP1804584A2 (de) 2007-07-11
EP1804584A4 true EP1804584A4 (de) 2009-08-05

Family

ID=36203535

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05810080A Ceased EP1804584A4 (de) 2004-10-14 2005-10-14 Verfahren und zusammensetzungen im zusammenhang mit der verabreichung eines ganoderma-lucidum-extrakts

Country Status (3)

Country Link
EP (1) EP1804584A4 (de)
JP (1) JP2008517100A (de)
WO (1) WO2006044616A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687064B2 (en) 2001-08-06 2010-03-30 Academia Sinica Methods and compositions associated with administration of an extract of Ganoderma lucidum
US7135183B1 (en) 2001-08-06 2006-11-14 Academia Sinica Immuno-modulating antitumor activities of Ganoderma lucidum (Reishi) polysaccharides
US8906380B2 (en) 2005-10-14 2014-12-09 Academia Sinica Fungal immunostimulatory compositions
JP6026715B2 (ja) * 2006-06-08 2016-11-16 株式会社アミノアップ化学 ｉＮＯＳの発現制御作用を有する組成物
EP2099465A4 (de) * 2006-09-21 2011-09-14 Academia Sinica Reishi-vermittelte verstärkte adhäsion und differenzierung menschlicher gewebevorläuferzellen
US7785600B2 (en) 2007-08-30 2010-08-31 Wyntek Corporation Compositions and methods for treating allergies, auto-immune diseases, and improving skin condition by ganoderma lucidum (reishi) polysaccharides
US7947283B2 (en) 2007-08-30 2011-05-24 Wyntek Corporation Compositions and methods for treating psoriasis by Ganoderma lucidum (Reishi) polysaccharides
US20090280062A1 (en) * 2008-04-17 2009-11-12 Chi-Huey Wong Longevity-promoting effects of acetic acid and reishi polysaccharide
TWI599370B (zh) * 2013-07-26 2017-09-21 中央研究院 靈芝多醣誘發之抗體介導抗腫瘤活性
CN104975041B (zh) * 2014-12-19 2018-01-23 中山大学 一种促进单核细胞向巨噬细胞分化的方法
JP7317358B2 (ja) * 2019-07-16 2023-07-31 日本メナード化粧品株式会社 造血幹細胞の分化促進剤
JPWO2023033128A1 (de) * 2021-09-03 2023-03-09

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6372629A (ja) * 1986-09-17 1988-04-02 Kyoritsu Yakuhin Kogyo Kk 霊芝から生理活性エキスを製造する方法
EP0288959B1 (de) * 1987-04-28 1994-01-12 Meiji Milk Products Company Limited Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens
US6613754B1 (en) * 2000-09-22 2003-09-02 National Yang-Ming University Polysaccharide-based extract from ganoderma, pharmaceutical use thereof, and process for preparing the same
US6464982B1 (en) * 2001-11-02 2002-10-15 Chinese Herbal Usa, Inc. Herbal immune system stimulant

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHEN H.-S. ET AL.: "Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides", BIOORG. & MEDICIN. CHEM., vol. 12, no. 21, 2004, pages 5595 - 5601, XP004588163 *
CHIEN C.M. ET AL.: "Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56+ NK-cell cytotoxicity in cord blood", BIOORG. & MEDICIN. CHEM., vol. 12, no. 21, 2004, pages 5603 - 5609, XP004588164 *
HSU H.-Y. ET AL.: "Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways", J. IMMUNOL., vol. 173, no. 10, 15 November 2004 (2004-11-15), pages 5989 - 5999, XP002533240 *
LIN K.-I. ET AL.: "Reishi polysaccharides induce immunoglobulin production through the TLR4/TLR2-mediated induction of transcription factor Blimp-1", J. BIOL. CHEM., vol. 281, no. 34, 25 August 2006 (2006-08-25), pages 24111 - 24123, XP002533242 *
SONG Y.S. ET AL.: "Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum", J. ETHNOPHARMACOL., vol. 90, no. 1, January 2004 (2004-01-01), pages 17 - 20, XP002533241 *
WANG Y.-Y. ET AL.: "Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities", BIOORG. & MEDICIN. CHEM., vol. 10, no. 4, April 2002 (2002-04-01), pages 1057 - 1062, XP002533239 *

Also Published As

Publication number Publication date
JP2008517100A (ja) 2008-05-22
WO2006044616A3 (en) 2006-08-24
EP1804584A2 (de) 2007-07-11
WO2006044616A2 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
EP1804584A4 (de) Verfahren und zusammensetzungen im zusammenhang mit der verabreichung eines ganoderma-lucidum-extrakts
EP1804823A4 (de) Neue cyclosporin-analoga und ihre pharmazeutischen anwendungen
EP1795004A4 (de) Bilderzeugungsanordnungen und verfahren dafür
CA118426S (en) Display screen
CA123441S (en) Display screen
AU321075S (en) Pet chew
EP1812102A4 (de) Okklusalstent und verwendungsverfahrn dafür
EP2182965A4 (de) Extrakte aus ligustrum lucidum und ihre verwendung
GB0422525D0 (en) Dermatological compositions and methods
IL206483A0 (en) Compositions and methods of using angiopoietin-like 4 protein
EP1781705A4 (de) Interferon-alpha-rezeptor-i-antikörper und ihre verwendung
PL1722710T3 (pl) Sposób oraz element znacznikowy do ustalania położenia implantu dentystycznego
EP1809656A4 (de) Cyclosporinalkinanaloga und deren pharmazeutische anwendungen
CA122774S (en) Bridge game cube die
CA118447S (en) Display screen
IL183021A0 (en) Synergistic effects of combined administration of mirtazapine and a stimulant compound
GB0419124D0 (en) Methods and compositions relating to Alzheimer's disease
IL182955A0 (en) Pharmaceutical compositions comprising a benzothiazol derivative and their use
EP1848444A4 (de) Verfahren zur herstellung von lactose unter verwendung von vorklassifizierungsverfahren sowie damit erzeugte pharmazeutische formulierungen
EP1907083A4 (de) Rennspiel und -verfahren
EP1778267A4 (de) Zusammensetzungen und verfahren in verbindung mit herzfehlfunktion
EP1945034A4 (de) Kräuterpulverextrakte und verfahren zu ihrer herstellung und anwendung
EP1541130A4 (de) Chinesische pflanzliche medizinzusammensetzung in form eines gelees
EP1811839A4 (de) Verfahren und zusammensetzungen in verbindung mit esculentosid a
FR2937534B1 (fr) Association d'un extrait d'orchidee et de la biotine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070502

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090708

17Q First examination report despatched

Effective date: 20091217

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20140313